Crossmark

Precision medicine drives epilepsy classification and therapy

Crossref DOI link: https://doi.org/10.1038/nrneurol.2017.190

Published Online: 2018-01-19

Published Print: 2018-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zuberi, Sameer M.

Brunklaus, Andreas
License Information

Text and Data Mining valid from 2018-01-19
More Information

Article History

First Online: 19 January 2018

Competing interests

: S.M.Z. has received honoraria for educational activities and advisory boards from GW Pharma, paid to his institution's charitable account. He was Chair of the International League Against Epilepsy Commission for Classification and Terminology from 2013–2017. A.B. declares no competing interests.